California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Dr. Shah performs spine and joint injections as well as advanced interventions such as spinal cord stimulators and intrathecal pain pumps for chronic pain. Viswanathan A, Vedantam A, Hess KR, Ochoa J, ...

Intrathecal Pain Pumps, like the spinal cord stimulator, is a specialized device that is surgically implanted under the skin. The pump delivers concentrated amounts of pain-relieving medications ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Pain medication isn’t the only option for pain relief. Next time you’re experiencing a toothache, back pain, or any other pain, you can try an herbal and natural pain reliever like turmeric ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...

Medtronic faced challenges ... The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article. This, combined with competition from pod-based ...

There are many possible causes of bone pain, including arthritis, fracture, and growing pains. Less commonly, it can point to bone cancer. Bone pain may present as tenderness initially ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...